US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
US Stocks Mixed; Abbott Reports Better-Than-Expected Q3 Results
In trading on Wednesday, communication services shares fell by 0.7%.U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 20 points on Wednesday.
美國股市今早交投混合，道瓊斯指數週三上漲約20點。
The Dow traded up 0.05% to 42,762.18 while the NASDAQ fell 0.06% to 18,305.30. The S&P 500 also fell, dropping, 0.07% to 5,811.21.
道瓊斯指數上漲0.05%，至42,762.18點，納斯達克指數下跌0.06%，至18,305.30點。標普500指數也下跌0.07%，至5,811.21點。
Leading and Lagging Sectors
Financials shares jumped by 0.7% on Wednesday.
領漲與跌幅最大的板塊：
週三，金融股上漲了0.7%。
In trading on Wednesday, communication services shares fell by 0.7%.
週三交易中，通訊服務股下跌了0.7%。
Top Headline
頭條新聞：
On Wednesday, Abbott Laboratories (NYSE:ABT) reported better-than-expected third-quarter results.
週三，雅培（紐交所：ABT）報告稱季度業績好於預期。
The company posted sales of $10.64 billion, up 4.9% year over year, beating the consensus of $10.55 billion. Abbott's adjusted diluted earnings per share was $1.21, beating the analyst estimates of $1.20.
該公司銷售額爲106.4億美元，同比增長4.9%，超過了105.5億的共識。雅培的調整後每股稀釋收益爲1.21美元，超過了分析師預期的1.20美元。
Equities Trading UP
股票上漲：
- 180 Life Sciences Corp (NASDAQ:ATNF) shares shot up 668% to $11.73. 180 Life Sciences interim CEO said that the company is planning to enter the online gaming industry with its newly acquired gaming technology platform.
- Shares of Santech Holdings Limited (NASDAQ:STEC) got a boost, surging 592% to $2.50.
- Versus Systems Inc. (NASDAQ:VS) shares were also up, gaining 422% to $5.90 after the company announced a $2.5 million investment and licensing agreement with ASPIS.
- 180 life sciences公司（納斯達克：ATNF）股價飆升668%，至11.73美元。 180 life sciences公司臨時CEO表示，公司計劃利用其新獲得的遊戲技術平台進軍在線遊戲行業。
- 聖泰克控股有限公司（納斯達克：STEC）股價大漲，漲幅達592%，至2.50美元。
- Versus Systems公司（納斯達克：VS）股價也上漲，漲幅422%，至5.90美元，此前該公司宣佈與ASPIS達成250萬美元的投資和許可協議。
Equities Trading DOWN
股票下跌：
- Bright Minds Biosciences Inc (NASDAQ:DRUG) shares dropped 39% to $23.39. Firefly Neuroscience collaborated with Bright Minds Biosciences to analyze the data from its positive Phase 1 study using its Artificial Intelligence.
- Shares of Silvaco Group, Inc. (NASDAQ:SVCO) were down 28% to $7.94 after the company reported a decline in orders from Asia during third quarter and cut its FY24 revenue outlook.
- Zapata Computing Holdings Inc. (NASDAQ:ZPTA) was down, falling 26% to $0.09.
- Bright Minds Biosciences公司（納斯達克：DRUG）股價下跌39%，至23.39美元。 Firefly Neuroscience與Bright Minds Biosciences合作，分析了其人工智能技術在積極的第一階段研究中的數據。
- Silvaco Group, Inc.公司（納斯達克：SVCO）股價下跌28%，至7.94美元，此前該公司報告稱在第三季度訂單從亞洲減少，削減了2024財年的營收預期。
- Zapata Computing Holdings Inc.公司（納斯達克：ZPTA）股價下跌26%，至0.09美元。
Commodities
In commodity news, oil traded down 0.1% to $70.53 while gold traded up 0.8% at $2,700.00.
商品雜項
在商品資訊中，原油交易下跌0.1%，至70.53美元，而黃金交易上漲0.8%，至2,700.00美元。
Silver traded up 1.8% to $32.325 on Wednesday, while copper rose 0.8% to $4.3725.
白銀交易上漲1.8%，至32.325美元，銅價上漲0.8%，至4.3725美元。
Euro zone
歐元區：
European shares were mixed today. The eurozone's STOXX 600 slipped 0.2%, Germany's DAX slipped 0.2% and France's CAC 40 fell 0.5%. Spain's IBEX 35 Index rose 0.4%, while London's FTSE 100 gained 0.9%.
歐洲股市今日表現不一。歐元區的STOXX 600下跌0.2%，德國的DAX下跌0.2%，法國的CAC 40下跌0.5%。西班牙的IBEX 35指數上漲0.4%，倫敦的FTSE 100指數上漲0.9%。
Asia Pacific Markets
亞太市場
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei 225 falling 1.83%, Hong Kong's Hang Seng Index falling 0.16%, China's Shanghai Composite Index gaining 0.05% and India's BSE Sensex falling 0.39%.
亞洲市場週三大多收低，日本的日經225指數下跌1.83%，香港的恒生指數下跌0.16%，中國的上海綜合指數上漲0.05%，印度的BSE Sensex指數下跌0.39%。
Economics
經濟學
- U.S. mortgage applications fell by 17% from the previous week during the second week of October.
- Export prices in the U.S. declined by 0.7% month-over-month in September, exceeding market estimates of a 0.4% fall.
- Import prices declined by 0.4% from the previous month in September.
- 美國10月第二週的抵押貸款申請比上一週下降了17%。
- 美國9月出口價格較上個月下降0.7%，超出市場估計的0.4%降幅。
- 進口價格較上個月9月下降0.4%。
Now Read This:
現在閱讀這個：
- Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
- 吉姆·克萊默: '我們需要更多鈾'，建議購買這支股票；表示諾和諾德公司'一針見血'與大型製藥公司的競爭。
譯文內容由第三人軟體翻譯。
